The investment case for a novel letrozole-misoprostol medical abortion combipack

  Concept Foundation     Switzerland

Concept Foundation aims to demonstrate if a quality assured letrozole and misoprostol regimen for MA will serve as an affordable alternative treatment to the existing MA regimens and will increase access to safe medical abortion in low- and middle-income country markets. Concept Foundation will establish an investment case, providing information for decision making towards product development for letrozole as an abortifacient with misoprostol.